Skip to main content
PMC home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1998;7(3):157–162. doi: 10.1080/09629359891081

Antioxidants and mucosa protectives: realistic therapeutic options in inflammatory bowel disease?

L Kruidenier 1, H W Verspaget 1
PMCID: PMC1781836  PMID: 9705602

Abstract

Oxidative damage is involved in the pathogenic process of idiopathic chronic inflammatory bowel disease. Although specific intervention in the oxidative cascade showed promising results in animal models and preliminary patient trials, the clinical efficacy of antioxidants still has to be established. Mucosa protection, for example by dietary fatty acids, seems to attenuate the intestinal inflammatory process as well but awaits definite clinical proof for the treatment of inflammatory bowel disease.

Full Text

The Full Text of this article is available as a PDF (221.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belluzzi A., Brignola C., Campieri M., Pera A., Boschi S., Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med. 1996 Jun 13;334(24):1557–1560. doi: 10.1056/NEJM199606133342401. [DOI] [PubMed] [Google Scholar]
  2. Blok W. L., Katan M. B., van der Meer J. W. Modulation of inflammation and cytokine production by dietary (n-3) fatty acids. J Nutr. 1996 Jun;126(6):1515–1533. doi: 10.1093/jn/126.6.1515. [DOI] [PubMed] [Google Scholar]
  3. Burke A., Lichtenstein G. R., Rombeau J. L. Nutrition and ulcerative colitis. Baillieres Clin Gastroenterol. 1997 Mar;11(1):153–174. doi: 10.1016/s0950-3528(97)90059-2. [DOI] [PubMed] [Google Scholar]
  4. Emerit J., Pelletier S., Tosoni-Verlignue D., Mollet M. Phase II trial of copper zinc superoxide dismutase (CuZnSOD) in treatment of Crohn's disease. Free Radic Biol Med. 1989;7(2):145–149. doi: 10.1016/0891-5849(89)90005-1. [DOI] [PubMed] [Google Scholar]
  5. Hori Y., Hoshino J., Yamazaki C., Sekiguchi T., Miyauchi S., Mizuno S., Horie K. Effect of lecithinized-superoxide dismutase on the rat colitis model induced by dextran sulfate sodium. Jpn J Pharmacol. 1997 May;74(1):99–103. doi: 10.1254/jjp.74.99. [DOI] [PubMed] [Google Scholar]
  6. Karmeli F., Eliakim R., Okon E., Samuni A., Rachmilewitz D. A stable nitroxide radical effectively decreases mucosal damage in experimental colitis. Gut. 1995 Sep;37(3):386–393. doi: 10.1136/gut.37.3.386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Keshavarzian A., Doria M. I., Sedghi S., Kanofsky J. R., Hecht D., Holmes E. W., Ibrahim C., List T., Urban G., Gaginella T. Mitomycin C-induced colitis in rats: a new animal model of acute colonic inflammation implicating reactive oxygen species. J Lab Clin Med. 1992 Nov;120(5):778–791. [PubMed] [Google Scholar]
  8. Keshavarzian A., Haydek J., Zabihi R., Doria M., D'Astice M., Sorenson J. R. Agents capable of eliminating reactive oxygen species. Catalase, WR-2721, or Cu(II)2(3,5-DIPS)4 decrease experimental colitis. Dig Dis Sci. 1992 Dec;37(12):1866–1873. doi: 10.1007/BF01308081. [DOI] [PubMed] [Google Scholar]
  9. Keshavarzian A., Morgan G., Sedghi S., Gordon J. H., Doria M. Role of reactive oxygen metabolites in experimental colitis. Gut. 1990 Jul;31(7):786–790. doi: 10.1136/gut.31.7.786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kim Y. I. Short-chain fatty acids in ulcerative colitis. Nutr Rev. 1998 Jan;56(1 Pt 1):17–24. doi: 10.1111/j.1753-4887.1998.tb01654.x. [DOI] [PubMed] [Google Scholar]
  11. Levin K. E., Pemberton J. H., Phillips S. F., Zinsmeister A. R., Pezim M. E. Role of oxygen free radicals in the etiology of pouchitis. Dis Colon Rectum. 1992 May;35(5):452–456. doi: 10.1007/BF02049401. [DOI] [PubMed] [Google Scholar]
  12. Mulder T. P., van der Sluys Veer A., Verspaget H. W., Griffioen G., Peña A. S., Janssens A. R., Lamers C. B. Effect of oral zinc supplementation on metallothionein and superoxide dismutase concentrations in patients with inflammatory bowel disease. J Gastroenterol Hepatol. 1994 Sep-Oct;9(5):472–477. doi: 10.1111/j.1440-1746.1994.tb01277.x. [DOI] [PubMed] [Google Scholar]
  13. Niwa Y., Somiya K., Michelson A. M., Puget K. Effect of liposomal-encapsulated superoxide dismutase on active oxygen-related human disorders. A preliminary study. Free Radic Res Commun. 1985;1(2):137–153. doi: 10.3109/10715768509056547. [DOI] [PubMed] [Google Scholar]
  14. Polson R. J., Misiewicz J. J. Medical management of severe inflammatory disease of the rectum and distal colon: non-nutritional aspects. Baillieres Clin Gastroenterol. 1992 Mar;6(1):1–26. doi: 10.1016/0950-3528(92)90015-7. [DOI] [PubMed] [Google Scholar]
  15. Salim A. S. Role of oxygen-derived free radical scavengers in the management of recurrent attacks of ulcerative colitis: a new approach. J Lab Clin Med. 1992 Jun;119(6):710–717. [PubMed] [Google Scholar]
  16. Yoshikawa T., Yamaguchi T., Yoshida N., Yamamoto H., Kitazumi S., Takahashi S., Naito Y., Kondo M. Effect of Z-103 on TNB-induced colitis in rats. Digestion. 1997;58(5):464–468. doi: 10.1159/000201484. [DOI] [PubMed] [Google Scholar]
  17. Yue G., Sun F. F., Dunn C., Yin K., Wong P. Y. The 21-aminosteroid tirilazad mesylate can ameliorate inflammatory bowel disease in rats. J Pharmacol Exp Ther. 1996 Jan;276(1):265–270. [PubMed] [Google Scholar]
  18. Zea-Iriarte W. L., Makiyama K., Goto S., Murase K., Urata Y., Sekine I., Hara K., Kondo T. Impairment of antioxidants in colonic epithelial cells isolated from trinitrobenzene sulphonic acid-induced colitis rats. Protective effect of rebamipide. Scand J Gastroenterol. 1996 Oct;31(10):985–992. doi: 10.3109/00365529609003118. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES